$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223042479 Filed on November 22, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$5.974M	$358.1K	$0.00
YoY Change		2009.99%	-100.0%
Cost Of Revenue	$627.2K	$296.7K	$0.00
YoY Change			-100.0%
Gross Profit	$5.347M	$61.45K	$0.00
YoY Change		262.04%	-100.0%
Gross Profit Margin	89.5%	17.16%
Selling, General & Admin	$1.478M	$1.019M	$4.193M
YoY Change	-64.76%	91.18%	186.28%
% of Gross Profit	27.64%	1658.33%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	-$760.00	$29.75K	$13.23K
YoY Change	-105.74%	124.68%	-7.87%
% of Gross Profit	-0.01%	48.41%
Operating Expenses	$1.478M	$1.019M	$4.193M
YoY Change	-64.76%	91.18%	186.28%
Operating Profit	$3.869M	-$957.6K	-$4.193M
YoY Change	-192.28%	85.56%	304.88%
Interest Expense	-$294.6K	$708.4K	-$1.989M
YoY Change	-85.19%	12.2%	374.48%
% of Operating Profit	-7.61%
Other Income/Expense, Net	$0.00	-$5.383M	$540.00
YoY Change	-100.0%	1065.13%
Pretax Income	$6.554M	-$6.340M	-$10.42M
YoY Change	-162.92%	548.23%	616.14%
Income Tax
% Of Pretax Income
Net Earnings	$6.554M	-$6.340M	-$10.42M
YoY Change	-162.92%	548.26%	616.14%
Net Earnings / Revenue	109.72%	-1770.41%
Basic Earnings Per Share		-$0.11
Diluted Earnings Per Share	$0.08	-$0.11	-$0.29
COMMON SHARES
Basic Shares Outstanding	75.42M shares	64.94M shares	36.80M shares
Diluted Shares Outstanding		64.44M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$140.3K	$120.0K	$49.37K
YoY Change	184.08%	25.21%	-12.76%
Cash & Equivalents	$140.2K	$123.1K	$49.37K
Short-Term Investments
Other Short-Term Assets	$16.82K	$20.00K	$49.20K
YoY Change	-65.81%	-90.3%	-80.45%
Inventory
Prepaid Expenses
Receivables	$1.652M	$1.652M	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.809M	$1.792M	$98.57K
YoY Change	1735.39%	401.37%	-84.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.819M	$1.815M	$1.069M
YoY Change	70.14%	-23.7%	-45.84%
Goodwill	$11.12M	$22.36M
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$53.47K	$50.38K	$0.00
YoY Change		-92.22%
Total Long-Term Assets	$28.54M	$25.44M	$1.069M
YoY Change	2570.12%	346.33%	-79.58%
TOTAL ASSETS
Total Short-Term Assets	$1.809M	$1.792M	$98.57K
Total Long-Term Assets	$28.54M	$25.44M	$1.069M
Total Assets	$30.35M	$27.23M	$1.168M
YoY Change	2499.65%	349.58%	-80.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.793M	$1.960M	$864.5K
YoY Change	107.4%	10.11%	-47.81%
Accrued Expenses	$1.757M	$1.820M	$485.7K
YoY Change	261.71%
Deferred Revenue	$93.38K	$93.38K	$85.41K
YoY Change	9.34%	-80.85%	-32.57%
Short-Term Debt	$9.585M	$9.547M	$1.845M
YoY Change	419.42%	635.02%	121.01%
Long-Term Debt Due	$2.675M	$2.290M	$1.886M
YoY Change	41.85%	3.67%	1734.97%
Total Short-Term Liabilities	$28.66M	$34.21M	$5.719M
YoY Change	401.12%	465.08%	108.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.66M	$34.21M	$5.719M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$28.66M	$34.21M	$5.719M
YoY Change	401.12%	465.08%	27.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.20M	-$33.70M	-$25.10M
YoY Change	8.37%	77.37%	70.7%
Common Stock	$79.66K	$75.40K	$43.50K
YoY Change	83.12%	106.72%	36.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$300.0K	$300.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.094M	-$7.587M	-$4.551M
YoY Change
Total Liabilities & Shareholders Equity	$30.35M	$27.23M	$1.168M
YoY Change	2499.65%	349.58%	-80.07%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	$6.554M	-$6.340M	-$10.42M
YoY Change	-162.92%	548.26%	616.14%
Depreciation, Depletion And Amortization	-$760.00	$29.75K	$13.23K
YoY Change	-105.74%	124.68%	-7.87%
Cash From Operating Activities	-$1.057M	-$820.0K	-$22.02K
YoY Change	4700.64%	366.31%	-93.37%
INVESTING ACTIVITIES
Capital Expenditures	$107.4K	$200.0K	$95.40K
YoY Change	12.62%	-256.01%	-133.98%
Acquisitions
YoY Change
Other Investing Activities	-$2.980K	$210.0K	$0.00
YoY Change
Cash From Investing Activities	-$110.4K	$10.00K	-$95.40K
YoY Change	15.74%	-107.8%	-66.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.188M	880.0K	70.95K
YoY Change	1574.98%	123.15%	-319.8%
NET CHANGE
Cash From Operating Activities	-1.057M	-820.0K	-22.02K
Cash From Investing Activities	-110.4K	10.00K	-95.40K
Cash From Financing Activities	1.188M	880.0K	70.95K
Net Change In Cash	20.88K	70.00K	-46.47K
YoY Change	-144.93%	-22.49%	-92.8%
FREE CASH FLOW
Cash From Operating Activities	-$1.057M	-$820.0K	-$22.02K
Capital Expenditures	$107.4K	$200.0K	$95.40K
Free Cash Flow	-$1.165M	-$1.020M	-$117.4K
YoY Change	891.77%	2040.61%	127.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001657214
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	ILAL	Convertible Note Acquisition ConvertibleNoteAcquisition		usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	ILAL	Common Stock Payable CommonStockPayable		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1		usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2023Q2	ILAL	Stock Issued During Period Value Stock Warrant Exercised StockIssuedDuringPeriodValueStockWarrantExercised		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1		usd
	ILAL	Penalty On Convertible Debt PenaltyOnConvertibleDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
	ILAL	Increase Decrease In Accrued Interest On Note Receivable IncreaseDecreaseInAccruedInterestOnNoteReceivable		usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	ILAL	Dividend On Series C DividendOnSeriesC		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	ILAL	Common Shares Issued With Convertible Related Party CommonSharesIssuedWithConvertibleRelatedParty		usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement		usd
	ILAL	Commitment Shares Issued With Convertible Note CommitmentSharesIssuedWithConvertibleNote		usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing		usd
	ILAL	Cashless Warrant Exercise CashlessWarrantExercise		usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote		usd
	ILAL	Convertible Debt Exchange For Related Party Note Payable ConvertibleDebtExchangeForRelatedPartyNotePayable		usd
	ILAL	Settlement Of Derivative Liability SettlementOfDerivativeLiability		usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56111
	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL LAND ALLIANCE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3752361
	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 10th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92101
	dei	City Area Code CityAreaCode	(877)
	dei	Local Phone Number LocalPhoneNumber	661-4811
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75422570	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	123117	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49374	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1652086	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16815	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49198	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1792018	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	98572	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	50382	usd
CY2023Q3	us-gaap	Land Land	1206219	usd
CY2022Q4	us-gaap	Land Land	203419	usd
CY2023Q3	ILAL	Buildings Buildings	1815040	usd
CY2022Q4	ILAL	Buildings Buildings	863745	usd
CY2023Q3	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	5473	usd
CY2022Q4	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	1877	usd
CY2023Q3	us-gaap	Goodwill Goodwill	22359972	usd
CY2023Q3	us-gaap	Assets Assets	27229104	usd
CY2022Q4	us-gaap	Assets Assets	1167613	usd
CY2023Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	9351815	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	93382	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	85407	usd
CY2023Q3	us-gaap	Deposits Deposits	20500	usd
CY2022Q4	us-gaap	Deposits Deposits	20500	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	696460	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	531527	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	625210	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	558657	usd
CY2023Q3	ILAL	Convertible Note Acquisition ConvertibleNoteAcquisition	8900000	usd
CY2023Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	6957504	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	34212120	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5718595	usd
CY2023Q3	us-gaap	Liabilities Liabilities	34212120	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5718595	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	603500	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75395165	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72395165	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43499423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43499423	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	75395	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	43500	usd
CY2023Q3	ILAL	Common Stock Payable CommonStockPayable	31939	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26355164	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20233446	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3000000	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	300000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33749046	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25121457	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-7586516	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27229104	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1167613	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	358129	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16973	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1084641	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50919	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	296680	usd
	us-gaap	Cost Of Revenue CostOfRevenue	300680	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	61449	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	16973	usd
	us-gaap	Gross Profit GrossProfit	783961	usd
	us-gaap	Gross Profit GrossProfit	50919	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	100600	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	300259	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	903283	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1007030	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	432434	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2316807	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2506181	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1019030	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	533034	usd
	us-gaap	Operating Expenses OperatingExpenses	2862740	usd
	us-gaap	Operating Expenses OperatingExpenses	3409464	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-957581	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-516061	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2078779	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3358545	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1091117	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1140446	usd
CY2023Q3	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1	2995000	usd
	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1	2995000	usd
CY2023Q3	ILAL	Change In Fair Value Derivative Liability ChangeInFairValueDerivativeLiability	-588314	usd
CY2022Q3	ILAL	Change In Fair Value Derivative Liability ChangeInFairValueDerivativeLiability	219069	usd
	ILAL	Change In Fair Value Derivative Liability ChangeInFairValueDerivativeLiability	-690091	usd
	ILAL	Change In Fair Value Derivative Liability ChangeInFairValueDerivativeLiability	219069	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-49752	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-231845	usd
	us-gaap	Interest Income Other InterestIncomeOther	536	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	708356	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	631308	usd
	us-gaap	Interest Expense InterestExpense	1723273	usd
	us-gaap	Interest Expense InterestExpense	960496	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5382787	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-461991	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6548810	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-972736	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6340368	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-978052	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8627589	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4331281	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1007822	usd
CY2022Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	15000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1082825	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	45000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7348190	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-993052	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9710413	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4376281	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64441149	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64441149	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36394441	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36394441	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62191188	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62191188	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34917678	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34917678	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1800000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	2674976	usd
CY2023Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	25354972	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	300000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	147805	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1908561	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-27707187	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18504	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q2	ILAL	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	3100	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-60003	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-378660	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-28049295	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	25354972	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	31939	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	137000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1534974	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	105392	usd
CY2023Q3	ILAL	Settlement Of Derivative Liability SettlementOfDerivativeLiability	518646	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-1007822	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-6340368	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-7586516	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	202275	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	447278	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	871688	usd
CY2022Q1	ILAL	Adjustments To Additional Paid In Capital Warrant Issued In Connection With Debt Financing AdjustmentsToAdditionalPaidInCapitalWarrantIssuedInConnectionWithDebtFinancing	159664	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1492722	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1262616	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	40490	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	700	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	729885	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	410288	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1860507	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	133334	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-978052	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-291246	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-291246	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8627589	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4331281	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	358037	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1281976	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1	2995000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	152000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1310497	usd
	ILAL	Penalty On Convertible Debt PenaltyOnConvertibleDebt	108096	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1140446	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89241	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	39708	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-231845	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	357376	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	291374	usd
	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt	108465	usd
	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt	356785	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-475114	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	219069	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-58764	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25199	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-32383	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-45557	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	7808	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	310182	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-235002	usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty	136970	usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty	411305	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	75195	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-579183	usd
	ILAL	Increase Decrease In Accrued Interest On Note Receivable IncreaseDecreaseInAccruedInterestOnNoteReceivable	5919	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	500	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	305909	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	340882	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1107362	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-506041	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	321920	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	205096	usd
	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	274846	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	354070	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	444535	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-101900	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-444535	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1300	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	250000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	318359	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	262596	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	89474	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	225000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	663250	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	270414	usd
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	380938	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	465000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	560840	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	677347	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1283005	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	989827	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	73743	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39251	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49374	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56590	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	123117	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	95841	usd
	us-gaap	Interest Paid Net InterestPaidNet	276963	usd
	us-gaap	Interest Paid Net InterestPaidNet	115084	usd
	ILAL	Dividend On Series B DividendOnSeriesB	1022822	usd
	ILAL	Dividend On Series B DividendOnSeriesB	45000	usd
	ILAL	Dividend On Series C DividendOnSeriesC	60003	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	156310	usd
	ILAL	Common Shares Issued With Convertible Related Party CommonSharesIssuedWithConvertibleRelatedParty	386023	usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement	40490	usd
	ILAL	Commitment Shares Issued With Convertible Note CommitmentSharesIssuedWithConvertibleNote	202275	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	31939	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	102200	usd
	ILAL	Debt Discount From Bifurcated Derivative DebtDiscountFromBifurcatedDerivative	100000	usd
	ILAL	Debt Discount From Bifurcated Derivative DebtDiscountFromBifurcatedDerivative	140750	usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing	159664	usd
	ILAL	Cashless Warrant Exercise CashlessWarrantExercise	267	usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote	49145	usd
	ILAL	Convertible Debt Exchange For Related Party Note Payable ConvertibleDebtExchangeForRelatedPartyNotePayable	182594	usd
	ILAL	Settlement Of Derivative Liability SettlementOfDerivativeLiability	518646	usd
CY2023Q3	ILAL	Working Capital WorkingCapital	32400000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8600000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33700000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zUn74WxHxJ9j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_z4df9ce41H9a">Reclassification</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain numbers from 2022 have been reclassified to conform with the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zesj24d7kndh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zNTgxeRjT5Oi">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful life of buildings.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowances.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived assets for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	696460	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	696460	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	531527	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	208464	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	-297566	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-480268	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	922693	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	295901	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	626792	usd
CY2023Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements	-221080	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-290748	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	696460	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	358129	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1084641	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	12000	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	100600	usd
	us-gaap	Advertising Expense AdvertisingExpense	300259	usd
	us-gaap	Advertising Expense AdvertisingExpense	903283	usd
CY2023Q3	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44107500	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7717500	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zdBd80PA01j2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zOSxFCdawCZ6">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	776381	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	184393	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1815040	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	863745	usd
CY2023Q3	us-gaap	Depreciation Depreciation	29747	usd
CY2022Q3	us-gaap	Depreciation Depreciation	13236	usd
	us-gaap	Depreciation Depreciation	89241	usd
	us-gaap	Depreciation Depreciation	39708	usd
CY2023Q3	ILAL	Notes Payable Gross NotesPayableGross	2294762	usd
CY2022Q4	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	4146	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	2294762	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1885616	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2294762	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1885616	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	4146	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	9547000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	771738	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	21790	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	213081	usd
CY2023Q3	us-gaap	Convertible Debt ConvertibleDebt	9525210	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	558657	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	9525210	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	558657	usd
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2680000	usd
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	0	usd
	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1	2995000	usd
CY2023Q3	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1	2995000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	22359972	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	360102	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	828804	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1090617	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1516622	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-370007	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-194372	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1110022	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-926798	usd
	us-gaap	Real Estate Owned Amount Of Loss At Acquisition1 RealEstateOwnedAmountOfLossAtAcquisition1	2995000	usd
CY2023Q3	us-gaap	Area Of Land AreaOfLand	20
CY2023Q3	ILAL	Net Budget NetBudget	1556000	usd
CY2023Q3	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	995747	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	560250	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2010000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75395165	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72395165	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43499423	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43499423	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3867500	shares
CY2022Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.71
CY2022	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P4Y1M9D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	34240000	shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.10
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted	P4Y9M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	38107500	shares
CY2023Q3	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.16
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P4Y2M1D
CY2023Q3	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	38107500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M17D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5731251	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	210485	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd

Files In Submission

Name	View Source	Status
0001493152-23-042479-index-headers.html	Edgar Link	pending
0001493152-23-042479-index.html	Edgar Link	pending
0001493152-23-042479.txt	Edgar Link	pending
0001493152-23-042479-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ilal-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
ilal-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ilal-20230930_lab.xml	Edgar Link	unprocessable
ilal-20230930_pre.xml	Edgar Link	unprocessable
ilal-20230930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2023 Q4 Form 10-Q Financial Statement

#000149315223042479 Filed on November 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2023 Q4 Form 10-Q Financial Statement

#000149315223042479 Filed on November 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal